Skip to content

Individualized Nutritional Counselling During Chemotherapy for Colorectal Cancer (COLONUT)

The Effect of Individualized NUTritional Counselling on Muscle Mass and Treatment Outcome in Patients With Metastatic COLOrectal Cancer Undergoing Chemotherapy: the COLONUT Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01998152
Acronym
COLONUT
Enrollment
107
Registered
2013-11-28
Start date
2013-11-30
Completion date
2018-12-15
Last updated
2018-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stage IV Colorectal Cancer

Brief summary

The purpose is to study the effect of individualized nutritional counselling compared to usual nutritional care on cross-sectional muscle area in patients with stage IV colorectal cancer during first line chemotherapy. Secondary, effect on total lean body mass, treatment intensity, physical functioning, quality of life and survival will be studied.We hypothesize that patients in the intervention arm benefit from individualized nutritional counseling.

Interventions

PROCEDURENutritional counseling

Patients in the intervention-arm will receive individualized nutritional counseling by a registered dietitian during standard treatment with chemotherapy. The main goals of the nutritional intervention will be to enable every patient to achieve sufficient protein and energy intake with attention for sufficient intake of micronutrients and a sufficient physical activity level.

Sponsors

Amsterdam UMC, location VUmc
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * Stage IV colorectal cancer * Scheduled for treatment with first line chemotherapy, either CAPOX(-B), FOLFOX(-B) or capecitabine(-B) * CT scan suitable for evaluating muscle mass at L3 level * Understanding of the Dutch language * Able and willing to give written informed consent

Exclusion criteria

* Chemotherapy in the previous three months * WHO performance status ≥ 3 * Long-term high dose of corticosteroids: ≥ three weeks ≥ ten milligram prednisolon or equivalent

Design outcomes

Primary

MeasureTime frameDescription
Change in skeletal muscle area (cm2) between individualized nutritional counselling versus usual nutritional careDuring 9 weeks of first line chemotherapywill be measured with SliceOmatic software V5.0 (Tomovision) with use of routinely conducted CT scans for diagnostic and disease evaluation purposes

Secondary

MeasureTime frameDescription
Change in total body lean body mass and segmental lean body mass (DEXA) in patients with stage IV colorectal cancer during 9 weeks of first line chemotherapy between individualized nutritional counseling versus usual nutritional careDuring 9 weeks of first line chemotherapy
Change in skeletal muscle area in patients with stage IV colorectal cancer during 20 weeks of first line chemotherapy between individualized nutritional counseling.versus usual nutritional care.During 20 weeks of first line chemotherapyChange in skeletal muscle area (cm2) between individualized nutritional counselling versus usual nutritional care
Composite of treatment toxicity, treatment intensity, treatment outcome, survival, physical functioning, quality of life and hand grip strength of both study armsDuring 9 weeks and during 20 weeks of first line chemotherapy
Associations of (changes in) muscle area with (changes in) mid-upper arm muscle circumference, whole body fat free mass (BIA) and whole body lean body mass (DEXA).During 9 weeks of first line chemotherapy

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026